Workflow
Digital Healthcare
icon
Search documents
Equasens: Appointment at the head of the Pharmagest Division
Globenewswire· 2025-07-03 16:00
Villers-lès-Nancy (France), July 03, 2025 – 06 :00pm (CET) Press Release Equasens announces the departure of Damien VALICON, as Deputy Chief Executive Officer and Director of the Pharmagest Division He will be replaced by François-Pierre MARQUIER as Director of the Pharmagest Division. *** Equasens Group (Euronext Paris™ - Compartment B - FR 0012882389 –$EQS), announces the departure of Damien VALICON, who held the position of Deputy Chief Executive Officer and Director of the Pharmagest Division for 18 mo ...
Equasens: General meeting - Results of the votes
Globenewswire· 2025-07-01 17:00
Villers-lès-Nancy, 1st July 2025 – 07:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2025 Number of shares comprising the share capital: 15,174,125 Number of shares with voting rights: 14,830,415 Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,173,125 That means a quorum of 88.83% of the 14,830,415 shares with voting rights: the Ordinary Annual General Me ...
Equasens: acquisition of DIS and RESURGENCES BUSINESSES
Globenewswire· 2025-06-30 16:00
Villers-lès-Nancy (France), 30 June 2025 - 06:00 PM (CET) PRESS RELEASE EQUASENS ACQUIRES DIS AND RESURGENCES BUSINESSES, STRENGTHENING ITS POSITION IN THE MARKET OF SOFTWARE SOLUTIONS FOR HEALTHCARE ESTABLISHMENTS. Strengthening the position of a leading provider of software solutions for hospitals and the medical-social sector Growth strategy in action This acquisition is fully in line with Equasens' strategy for: developing software solutions for public health establishments, a market with numerous renew ...
Hims & Hers stock rockets on news of European launch
Finbold· 2025-06-03 13:15
Hims & Hers Health (NYSE: HIMS) experienced a notable uptick in its stock price following the announcement of its planned acquisition of ZAVA, a prominent European digital health platform. The stock rose 7.77% in pre-market trading on June 3, 2025, reflecting investor optimism about the company’s strategic expansion into Europe. HIMS shares closed at $56.77 on Monday, reflecting a year-to-date increase of approximately 134.78% and a 39.07% gain over the past month. HIMS stock climbs over 7% in pre-market. S ...
Stryker(SYK) - 2025 FY - Earnings Call Transcript
2025-05-08 14:30
Stryker (SYK) FY 2025 Annual General Meeting May 08, 2025 09:30 AM ET Speaker0 Welcome to Stryker's Annual Meeting of Shareholders. This meeting is being recorded. Before we begin, I would like to remind you that the discussions during the meeting will include forward looking statements. Factors that could cause actual results to differ materially are discussed in the company's most recent filings with the SEC. Also, the discussions will include certain non GAAP financial measures. Reconciliations to the mo ...
Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?
ZACKS· 2025-04-30 17:45
Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space. This is bringing a new class of tech-driven innovators to the forefront. Hims & Hers Health, Inc. (HIMS) and Teladoc Health, Inc. (TDOC) stand out as emerging players in the rapidly evolving digital health space, providing remote consultations and health management solutions to consumers.Hims & Hers is a consumer-first platform transforming the way customers fulfill their health and ...